AVENIO Tumor Tissue Targeted Kit – Tumor Profiling

Material Number: N/A

Next-generation sequencing (NGS) liquid biopsy assay specially designed to monitor tumor burden in lung and colorectal cancer over time, as well as to assess for minimal residual disease (MRD). Contains 471 frequently mutated regions associated with the presence of disease across 197 genes.

Description

Roche AVENIO Tumor Tissue Targeted Kits enable monitoring tumor burden in lung and colorectal cancer over time, as well as to assess for minimal residual disease.